PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AXLA vs. OLMA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


AXLAOLMA

Fundamentals


AXLAOLMA
Market Cap$1.18M$555.23M
EPS-$18.25-$2.14
Revenue (TTM)$0.00$0.00
Gross Profit (TTM)$0.00$0.00
EBITDA (TTM)-$41.30M-$104.58M

Correlation

-0.50.00.51.00.1

The correlation between AXLA and OLMA is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

AXLA vs. OLMA - Performance Comparison

The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%20.00%40.00%NovemberDecember2024FebruaryMarchApril
-93.87%
-21.01%
AXLA
OLMA

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Axcella Health Inc.

Olema Pharmaceuticals, Inc.

Risk-Adjusted Performance

AXLA vs. OLMA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Axcella Health Inc. (AXLA) and Olema Pharmaceuticals, Inc. (OLMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AXLA
Sharpe ratio
The chart of Sharpe ratio for AXLA, currently valued at -0.27, compared to the broader market-2.00-1.000.001.002.003.00-0.27
Sortino ratio
The chart of Sortino ratio for AXLA, currently valued at -0.03, compared to the broader market-4.00-2.000.002.004.006.00-0.03
Omega ratio
The chart of Omega ratio for AXLA, currently valued at 1.00, compared to the broader market0.501.001.501.00
Calmar ratio
The chart of Calmar ratio for AXLA, currently valued at -0.96, compared to the broader market0.001.002.003.004.005.006.00-0.96
Martin ratio
The chart of Martin ratio for AXLA, currently valued at -1.27, compared to the broader market0.0010.0020.0030.00-1.27
OLMA
Sharpe ratio
The chart of Sharpe ratio for OLMA, currently valued at 1.72, compared to the broader market-2.00-1.000.001.002.003.001.72
Sortino ratio
The chart of Sortino ratio for OLMA, currently valued at 2.37, compared to the broader market-4.00-2.000.002.004.006.002.37
Omega ratio
The chart of Omega ratio for OLMA, currently valued at 1.28, compared to the broader market0.501.001.501.28
Calmar ratio
The chart of Calmar ratio for OLMA, currently valued at 1.63, compared to the broader market0.001.002.003.004.005.006.001.63
Martin ratio
The chart of Martin ratio for OLMA, currently valued at 7.69, compared to the broader market0.0010.0020.0030.007.69

AXLA vs. OLMA - Sharpe Ratio Comparison


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.006.00NovemberDecember2024FebruaryMarchApril
-0.27
1.72
AXLA
OLMA

Dividends

AXLA vs. OLMA - Dividend Comparison

Neither AXLA nor OLMA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

AXLA vs. OLMA - Drawdown Comparison


-100.00%-95.00%-90.00%-85.00%-80.00%-75.00%-70.00%-65.00%NovemberDecember2024FebruaryMarchApril
-99.76%
-81.38%
AXLA
OLMA

Volatility

AXLA vs. OLMA - Volatility Comparison

The current volatility for Axcella Health Inc. (AXLA) is 0.00%, while Olema Pharmaceuticals, Inc. (OLMA) has a volatility of 16.17%. This indicates that AXLA experiences smaller price fluctuations and is considered to be less risky than OLMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%NovemberDecember2024FebruaryMarchApril0
16.17%
AXLA
OLMA

Financials

AXLA vs. OLMA - Financials Comparison

This section allows you to compare key financial metrics between Axcella Health Inc. and Olema Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items